Research Conducted By Local Oncologist Presented At National Meeting

Highlands Oncology Group Physician Collaborated On Research Presented at Annual Oncological Meeting.

Dr. J. Thaddeus Beck, of Highlands Oncology Group (HOG), collaborated on research that will be introduced at the annual American Society of Clinical Oncology meeting in Chicago.

The research, entitled “Genomic Mutation Profiling (GMP) and Clinical Outcome of Patients Treated with Buparlisib (PI3K inhibitor) in the “Signature” Program,” has been selected for presentation and discussion session. 

In 2015, there will be an estimated 1,658,370 new cancer cases diagnosed and 589,430 cancer deaths in the United States alone, according to the American Cancer Society. 

An annual ASCO meeting is held where oncologists from around the country meet to discuss breakthroughs or changes in medical oncology treatment and awareness, to present lectures and presentations and to provide educational experiences on concentrated topics in clinical oncology. 

The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, according to the ASCO website. The 2015 meeting will take place from May 29 to June 2.

As the leading cancer treatment and research facility in Northwest Arkansas, HOG is dedicated to the advancement of cancer treatment and to providing patients with the best possible care and results.


Highlands Oncology Group is a state-of-the-art facility, with a world-class team of specialists, that is committed to providing premier cancer treatment and to enhancing the quality of life of patients and their loved ones. Highlands Oncology group provides this in a friendly, comfortable environment conveniently located in Northwest Arkansas. Highlands offers the latest technology of diagnostic imaging and radiation therapies, on-site labs, a pharmacy and an infusion center. They also offer access to clinical trials, multidisciplinary clinics and support groups. Highlands Oncology Group is helping patients win the battle against cancer every day.

For more information visit